Advanced Enzyme Technologies' Q2 FY 2025-26 Quarterly Results

Result Summary

• Advanced Enzyme Technologies Ltd reported a 0.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 25.1%.
• Its expenses for the quarter were down by 3.3% QoQ and up 19.2% YoY.
• The net profit increased 10.6% QoQ and increased 34.0% YoY.
• The earnings per share (EPS) of Advanced Enzyme Technologies Ltd stood at 3.87 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Advanced Enzyme Technologies Ltd is a company that operates within the biotechnology industry, focusing primarily on the development and production of enzyme-based products. These products are utilized across various industries, including pharmaceuticals, food and beverages, and animal nutrition, among others. Enzymes are biological catalysts that accelerate chemical reactions, making them valuable in numerous applications for improving efficiency and sustainability. As of the most recent data available up to October 2023, Advanced Enzyme Technologies Ltd has been actively pursuing growth through innovation and expansion into new markets. However, detailed information regarding recent major developments for the company beyond this timeframe is not available.

Revenue

In the second quarter of the fiscal year 2026 (Q2FY26), Advanced Enzyme Technologies Ltd reported a total income of ₹194.81 crores, which remains nearly unchanged from ₹194.76 crores in the first quarter of fiscal year 2026 (Q1FY26), reflecting a 0.0% quarter-over-quarter (QoQ) growth. However, on a year-over-year (YoY) basis, there is a significant increase of 25.1% from ₹155.71 crores reported in the second quarter of fiscal year 2025 (Q2FY25). This increase highlights a strong upward trend in revenue when compared annually, showcasing the company's capacity to generate higher income over the period.

Profitability

The profitability metrics for Advanced Enzyme Technologies Ltd demonstrate positive growth. For Q2FY26, the company recorded a profit before tax of ₹59.54 crores, reflecting an 8.5% QoQ growth from ₹54.90 crores in Q1FY26, and a 41.1% YoY increase from ₹42.21 crores in Q2FY25. The profit after tax for Q2FY26 was ₹44.74 crores, which is a 10.6% increase from the ₹40.44 crores in Q1FY26 and a 34.0% increase from ₹33.39 crores in Q2FY25. Earnings per share also increased to ₹3.87 in Q2FY26 from ₹3.57 in Q1FY26, marking an 8.4% QoQ growth, and a 32.1% YoY increase from ₹2.93 in Q2FY25. The substantial YoY increase in profits and earnings per share indicates that the company's profitability has significantly improved over the past year.

Operating Metrics

The operating expenses of Advanced Enzyme Technologies Ltd saw a reduction in Q2FY26 compared to Q1FY26, with total expenses reported at ₹135.27 crores, down by 3.3% from ₹139.86 crores. This decline in expenses contributes positively to the company's operating efficiency on a QoQ basis. However, when compared YoY, there is a 19.2% increase from ₹113.51 crores in Q2FY25, indicating a rise in operational costs over the year. The tax expense for Q2FY26 was ₹14.81 crores, a 2.4% increase from Q1FY26's ₹14.46 crores, and a significant 67.9% increase from ₹8.82 crores in Q2FY25. This increase in tax expense on a YoY basis may reflect changes in tax regulations or adjustments in the company's taxable income.